Author: Dr. David Lowemann

Novo Nordisk to Study GLP-1 Drugs for Addiction

Novo Nordisk will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst Lange told an online press conference on Thursday. GLP-1 drugs on the market include Novo Nordisk’s diabetes drug Ozempic, its weight-loss treatment… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on March 6, 2025

For Seniors With Hoarding Disorder, a Support Group Helps Confront Stigma and Isolation

A dozen people seated around folding tables clap heartily for a beaming woman: She’s donated two 13-gallon garbage bags full of clothes, including several Christmas sweaters and a couple of pantsuits, to a Presbyterian church. A closet cleanout might not seem a significant accomplishment. But as the people in this Sunday-night class can attest, getting […]

Published on March 6, 2025

My compliments to the chef: Researcher studies robots in the kitchen

Walking into your favorite restaurant and seeing a robot chef in the kitchen may seem far-fetched, but new research suggests that bots could be a solution to persistent labor shortages in the industry. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of […]

Published on March 5, 2025